People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Other Health Care, Biotech, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Intrapace Inc | — | Other Health Care | Series D+ | $179.1M | $76.8M | 2010 |
| CurvaFix, Inc. | — | Other Health Care | Series C | $50.7M | $478.1M | 2018 |
| Cyrus Biotechnology, Inc. | — | Biotech | Series B | $37.4M | $5.2M | 2017 |
| SmileMD Holdings, Inc. | — | Other | Series A | $17.4M | $10.3M | 2024 |
| Blue Duck Express, Inc. | — | Other | Series B | $13.6M | $4.5M | 2019 |
| Csats Inc. | — | Other Technology | Seed | $6.3M | $111.9M | 2016 |
| YoBucko, Inc. | — | Other Technology | Pre-Seed | $125K | $5.3M | 2011 |
Eric Bell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eric Bell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jason Smith | 1 | 14 |
| Chad Waite | 1 | 11 |
| Manish Agarwal | 1 | 9 |
| TING PAU OEI | 1 | 7 |
| J. Daniel Cole | 1 | 7 |
| Martin Dieck | 1 | 7 |
| Mir Imran | 1 | 6 |
| Paul Bell | 1 | 6 |
| Mark Foster | 1 | 6 |
| Marc-Andre Marcotte | 1 | 6 |
| Trevor Moody | 1 | 5 |
| Kurt Jacobus | 1 | 5 |
| Gus Tai | 1 | 4 |
| Henry Albrecht | 1 | 4 |
| MARK BENJAMIN | 1 | 3 |
| Derek Streat | 1 | 3 |
| Thomas Lendvay | 1 | 3 |
| Steven Dimmer | 1 | 2 |
| Wayne Roe | 1 | 2 |
| Chris Rowland | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.